Report error Found 16 Enz. Inhib. hit(s) with all data for entry = 12131
TargetRAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [1-169,G12D](Human)
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 0.230nMAssay Description:GppNp-loaded HIS-KRAS(G12D, aa 1-169) was pre-incubated with a compound in the presence of 200 uM GTP in a 384-well plate (Greiner) for 15 min, then ...More data for this Ligand-Target Pair
TargetRAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [1-169,G12D](Human)
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 0.452nMAssay Description:GppNp-loaded HIS-KRAS(G12D, aa 1-169) was pre-incubated with a compound in the presence of 200 uM GTP in a 384-well plate (Greiner) for 15 min, then ...More data for this Ligand-Target Pair
TargetRAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [1-169,G12D](Human)
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 0.659nMAssay Description:GppNp-loaded HIS-KRAS(G12D, aa 1-169) was pre-incubated with a compound in the presence of 200 uM GTP in a 384-well plate (Greiner) for 15 min, then ...More data for this Ligand-Target Pair
TargetRAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [1-169,G12D](Human)
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 0.691nMAssay Description:GppNp-loaded HIS-KRAS(G12D, aa 1-169) was pre-incubated with a compound in the presence of 200 uM GTP in a 384-well plate (Greiner) for 15 min, then ...More data for this Ligand-Target Pair
TargetRAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [1-169,G12D](Human)
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 1.15nMAssay Description:GppNp-loaded HIS-KRAS(G12D, aa 1-169) was pre-incubated with a compound in the presence of 200 uM GTP in a 384-well plate (Greiner) for 15 min, then ...More data for this Ligand-Target Pair
TargetRAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [1-169,G12D](Human)
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 1.16nMAssay Description:GppNp-loaded HIS-KRAS(G12D, aa 1-169) was pre-incubated with a compound in the presence of 200 uM GTP in a 384-well plate (Greiner) for 15 min, then ...More data for this Ligand-Target Pair
TargetRAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [1-169,G12D](Human)
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 2.5nMAssay Description:GppNp-loaded HIS-KRAS(G12D, aa 1-169) was pre-incubated with a compound in the presence of 200 uM GTP in a 384-well plate (Greiner) for 15 min, then ...More data for this Ligand-Target Pair
TargetRAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [1-169,G12D](Human)
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 7.24nMAssay Description:GppNp-loaded HIS-KRAS(G12D, aa 1-169) was pre-incubated with a compound in the presence of 200 uM GTP in a 384-well plate (Greiner) for 15 min, then ...More data for this Ligand-Target Pair
TargetRAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [1-169,G12D](Human)
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 11nMAssay Description:GppNp-loaded HIS-KRAS(G12D, aa 1-169) was pre-incubated with a compound in the presence of 200 uM GTP in a 384-well plate (Greiner) for 15 min, then ...More data for this Ligand-Target Pair
TargetRAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [1-169,G12D](Human)
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 32.6nMAssay Description:GppNp-loaded HIS-KRAS(G12D, aa 1-169) was pre-incubated with a compound in the presence of 200 uM GTP in a 384-well plate (Greiner) for 15 min, then ...More data for this Ligand-Target Pair
TargetRAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [1-169,G12D](Human)
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 35.8nMAssay Description:GppNp-loaded HIS-KRAS(G12D, aa 1-169) was pre-incubated with a compound in the presence of 200 uM GTP in a 384-well plate (Greiner) for 15 min, then ...More data for this Ligand-Target Pair
TargetRAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [1-169,G12D](Human)
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 81nMAssay Description:GppNp-loaded HIS-KRAS(G12D, aa 1-169) was pre-incubated with a compound in the presence of 200 uM GTP in a 384-well plate (Greiner) for 15 min, then ...More data for this Ligand-Target Pair
TargetRAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [1-169,G12D](Human)
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 86.1nMAssay Description:GppNp-loaded HIS-KRAS(G12D, aa 1-169) was pre-incubated with a compound in the presence of 200 uM GTP in a 384-well plate (Greiner) for 15 min, then ...More data for this Ligand-Target Pair
TargetRAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [1-169,G12D](Human)
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 294nMAssay Description:GppNp-loaded HIS-KRAS(G12D, aa 1-169) was pre-incubated with a compound in the presence of 200 uM GTP in a 384-well plate (Greiner) for 15 min, then ...More data for this Ligand-Target Pair
TargetRAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [1-169,G12D](Human)
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 880nMAssay Description:GppNp-loaded HIS-KRAS(G12D, aa 1-169) was pre-incubated with a compound in the presence of 200 uM GTP in a 384-well plate (Greiner) for 15 min, then ...More data for this Ligand-Target Pair
TargetRAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [1-169,G12D](Human)
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 3.86E+3nMAssay Description:GppNp-loaded HIS-KRAS(G12D, aa 1-169) was pre-incubated with a compound in the presence of 200 uM GTP in a 384-well plate (Greiner) for 15 min, then ...More data for this Ligand-Target Pair
